Ann: Appendix 3X & 3Z, page-5

I'm with you on that Psych , The only thing I can see that could be improved is an Update of the History,,, companies have been demonstrating their timeline,, so emphasizing what has been achieved to date,,, this shows a small time line to the finish ,,especially for PAA... 

Sure the company has had to overcome issues but Management have demonstrated resolve and continued to progress the MPL toward commercialisation.

I have not been able to locate another ASX Biotech that has a take out agreement let alone a take out agreement with a super power like Elanco. 

Over the years I have seen Biotechs make Discoveries only to leave the Lab and enter the Business wilderness knocking on doors ,taking rejection and then having to go the long road and commercialise (Manufacture , Sell and Distribute) themselves.

I have commended the Management team before for even sitting at the table with Elanco would be no small fete. Then getting ink on paper is a coup. From my perspective PA need to satisfy Elanco with MPL Phase II results ( meeting the Primary endpoint) and it's a Home Run,,out of the ball park, into the back of the carpark.......

Plus , it's a feel good product,, "saving mans best friend , heck even extending quality of life for mans best friend" at a reasonable cost with out the side effects of Chemo.... easy sell to the Market....  I reckon a Facebook page could bring in a Million followers easy............